Results 171 to 180 of about 349,116 (315)

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi   +26 more
wiley   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

open access: yesMolecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam   +9 more
wiley   +1 more source

Characterization of Opioid Agonist Morphine Derivatives with Emphasis on Medicinal Chemistry. [PDF]

open access: yesChemMedChem
Malik A   +7 more
europepmc   +1 more source

Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae) [PDF]

open access: green, 2007
Anita Brinker   +3 more
openalex   +1 more source

The Future of Medicinal Chemistry [PDF]

open access: yesAngewandte Chemie International Edition, 2012
Rainer Metternich, Torsten Hoffmann
openaire   +3 more sources

Home - About - Disclaimer - Privacy